Bactiguard Holding AB
STO:BACTI B
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
33.4
93.9
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one BACTI B stock under the Base Case scenario is 28.27 SEK. Compared to the current market price of 34.4 SEK, Bactiguard Holding AB is Overvalued by 18%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Bactiguard Holding AB
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for BACTI B cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Bactiguard Holding AB
Balance Sheet Decomposition
Bactiguard Holding AB
Current Assets | 203.7m |
Cash & Short-Term Investments | 106.4m |
Receivables | 52.6m |
Other Current Assets | 44.8m |
Non-Current Assets | 472.4m |
PP&E | 114.1m |
Intangibles | 339.3m |
Other Non-Current Assets | 19m |
Current Liabilities | 298m |
Accounts Payable | 31.8m |
Accrued Liabilities | 51.8m |
Other Current Liabilities | 214.4m |
Non-Current Liabilities | 49.7m |
Long-Term Debt | 44.5m |
Other Non-Current Liabilities | 5.3m |
Earnings Waterfall
Bactiguard Holding AB
Revenue
|
255m
SEK
|
Cost of Revenue
|
-133.8m
SEK
|
Gross Profit
|
121.2m
SEK
|
Operating Expenses
|
-170.6m
SEK
|
Operating Income
|
-49.4m
SEK
|
Other Expenses
|
-6.7m
SEK
|
Net Income
|
-56.1m
SEK
|
Free Cash Flow Analysis
Bactiguard Holding AB
SEK | |
Free Cash Flow | SEK |
BACTI B Profitability Score
Profitability Due Diligence
Bactiguard Holding AB's profitability score is 29/100. The higher the profitability score, the more profitable the company is.
Score
Bactiguard Holding AB's profitability score is 29/100. The higher the profitability score, the more profitable the company is.
BACTI B Solvency Score
Solvency Due Diligence
Bactiguard Holding AB's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Score
Bactiguard Holding AB's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BACTI B Price Targets Summary
Bactiguard Holding AB
Dividends
Current shareholder yield for BACTI B is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
BACTI B Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Bactiguard Holding AB is a medical device company, which engages in the development and supply of infection protection solutions. The company is headquartered in Stockholm, Stockholm and currently employs 188 full-time employees. The company went IPO on 2014-06-19. Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. The company consists of the noble metals: gold, palladium and silver, which reduces the adhesion of bacteria to the coated surfaces. Its product portfolio includes: BIP Foley Catherer, made from medical grade latex, and BIP Foley Catheter - Silicone, used for drainage and irrigation of the bladder; BIP Endotracheal Tube, for general anesthesia, intensive care, and emergency medicine for airway management and mechanical ventilation; and BIP Central Venous Catherer, made of polyurethane and used to administer drugs and intravenous solutions, monitor pressure and blood sampling. The firm is also present in Portugal, via a distribution agreement with Socime Medical Ltd, and Zambia.
Contact
IPO
Employees
Officers
The intrinsic value of one BACTI B stock under the Base Case scenario is 28.27 SEK.
Compared to the current market price of 34.4 SEK, Bactiguard Holding AB is Overvalued by 18%.